Wegovy HD 7.2 mg: Who Qualifies, Cost & Side Effects

Wegovy HD 7.2 mg is the new high-dose version of Wegovy: the same semaglutide you already know, at three times the standard 2.4 mg maintenance dose. The FDA approved it on March 19, 2026, it reached U.S. pharmacies in April, and by now it is stocked nationwide. If you have plateaued on 2.4 mg, or you are simply curious what “HD” means for results, cost, and side effects, this guide walks through who qualifies, what the trials showed, what you will actually pay, and why a surprising number of people report tingling skin after stepping up.

What Is Wegovy HD 7.2 mg?

Wegovy HD is a once-weekly semaglutide injection at 7.2 mg, delivered in a single-dose pen. It is approved for adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related condition, as an add-on to diet and physical activity. It was the fourth product cleared under the FDA’s new National Priority Voucher pilot, which is why the review took only about eight weeks, as reported by AJMC.

A few things Wegovy HD is not:

• It is not a starting dose. You still begin at 0.25 mg and climb the standard ladder.
• It is not a different drug. Semaglutide is semaglutide; the dose is what changed.
• It is not the Wegovy pill. The oral version tops out at 25 mg daily and is a separate product (see our Wegovy pill guide).

Who Qualifies for Wegovy HD 7.2 mg?

In practice, prescribers are reserving Wegovy HD 7.2 mg for people who meet three conditions:

• You are already on 2.4 mg. The label calls for at least four weeks at the standard maintenance dose before stepping up, so your body is adjusted to semaglutide.
• You are tolerating 2.4 mg well. If nausea, reflux, or constipation are still a daily struggle, most prescribers will hold the dose rather than triple it.
• You need more weight loss. The typical candidate has stalled on 2.4 mg for several months and is still above their health goal. Our GLP-1 plateau guide covers what else to check before asking for a higher dose.

Because the jump from 2.4 mg to 7.2 mg is a single step (there is no 4 mg or 5 mg rung in between), the decision belongs to you and your prescriber. Keeping a clean dose history and a weekly weight trend makes that conversation much easier, and you can track both free with Pep, logging each shot with its exact mg so your history shows the step-up clearly.

How Much More Weight Loss Does Wegovy HD Deliver?

The approval rests on the 72-week STEP UP trial, which randomized 1,407 adults with obesity to 7.2 mg, 2.4 mg, or placebo alongside lifestyle support. Here is how the doses compared:

• 20.7% average weight loss on 7.2 mg (the treatment-policy estimate Novo Nordisk cites), versus about 18% on 2.4 mg and under 4% on placebo.
• 31% of people on 7.2 mg lost 25% or more of their body weight, roughly double the share on 2.4 mg.
• In the companion STEP UP T2D trial, adults with type 2 diabetes lost about 13% on 7.2 mg.

So the realistic expectation is an extra two to three percentage points of weight loss over the standard dose, with a bigger share of people reaching the very high responder tier. Those are averages; individual results vary widely. To see what the trial curves imply for your own starting weight, run the numbers in our free GLP-1 weight loss calculator. If you are weighing Wegovy HD against a tirzepatide switch instead, Zepbound vs Wegovy compares the two head to head.

Wegovy HD Cost in 2026

Cost is where Wegovy HD 7.2 mg differs most from the standard doses, and the numbers depend entirely on how you pay:

• Self-pay through NovoCare Pharmacy: $399 per month for Wegovy HD (one box of four pens), compared with $349 per month for the 0.25 mg to 2.4 mg doses.
• List price at retail: roughly $1,350 to $1,500 per month before any coupon, so avoid paying cash at the counter without a savings offer applied.
• Commercial insurance: most plans that cover Wegovy 2.4 mg also cover HD, but expect a prior authorization documenting your time on 2.4 mg. The Wegovy savings card can lower copays for eligible commercially insured patients.
• Medicare Part D: eligible members can get any strength, including HD, for a $50 copay under the temporary Medicare GLP-1 Bridge. Our Medicare GLP-1 coverage guide explains who qualifies.

Prices and programs change often, so confirm current terms on the official NovoCare Wegovy page before you fill. To see how a $399 self-pay plan compares with your insurance copay over a full year, try our free GLP-1 cost calculator, and read the GLP-1 cost guide for other ways to pay less.

The Tingling Side Effect: Dysesthesia on Wegovy HD 7.2 mg

Most Wegovy HD side effects are the familiar semaglutide ones: nausea, constipation, diarrhea, and fatigue, usually strongest in the first few weeks after the step-up. The new one is dysesthesia, an altered or abnormal skin sensation. People describe it as tingling, pins and needles, heightened sensitivity to touch, or a mild burning feeling, often on the arms, legs, or torso.

In STEP UP, about 22% of people on 7.2 mg reported altered skin sensation, compared with roughly 6% on 2.4 mg and none on placebo. A few reassuring details from the data:

• Most cases were mild to moderate and improved on their own over time or after dropping back to 2.4 mg.
• Trial investigators classified it as a dose-related sensory side effect, and it was not a common reason for stopping treatment.
• Only about 3% of people on 7.2 mg stopped the medication because of side effects of any kind.

Still, tingling that is new, spreading, or paired with weakness or numbness deserves a call to your prescriber. Logging when it starts, where it shows up, and how it tracks with your dose day is exactly the kind of note that helps them decide whether to hold, reduce, or continue. For the GI side of things, our GLP-1 side effects guide covers prevention and relief.

Practical Tips for Stepping Up to 7.2 mg

If you and your prescriber decide Wegovy HD is the right move, a few habits make the transition smoother:

• Keep your dose day. The 7.2 mg pen is still once weekly, and the missed-dose rule is unchanged: take a late dose within five days, otherwise skip it. Our missed dose calculator gives the label guidance based on how late you are.
• Rotate injection sites. Belly, thigh, or upper arm, moving each week.
• Eat smaller and slower for the first month. Appetite suppression steps up along with the dose, and so can reflux.
• Prioritize protein and strength work. Losing 20% or more of your body weight raises the stakes on muscle preservation. Our GLP-1 protein calculator sets a daily target.
• Watch for tingling and note it. A one-line entry on the day it starts is more useful to your prescriber than trying to remember a month later.

Wegovy HD 7.2 mg FAQ

Can I start Wegovy on the 7.2 mg dose?

No. Wegovy HD 7.2 mg is a step-up dose for people who have been on 2.4 mg for at least four weeks and tolerate it well. Everyone still starts at 0.25 mg and titrates up over about four months.

Is Wegovy HD better than Zepbound?

Trial averages are close: about 20.7% weight loss for Wegovy HD 7.2 mg versus 20% to 22% for Zepbound 15 mg, though the studies were not head to head. The better choice usually comes down to insurance coverage, which side effects you tolerate, and whether you are already doing well on semaglutide.

Does the tingling from Wegovy HD go away?

For most people in the trials, yes. Dysesthesia on Wegovy HD 7.2 mg was generally mild, and it typically eased over time or after returning to 2.4 mg. Report new or worsening symptoms to your prescriber rather than waiting it out on your own.

This article is for educational purposes only and is not medical advice. Always follow your healthcare provider’s instructions for your medication.